LXRX FY 2020 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$24M-92.5% YoY

Gross Profit

$22M92.0% margin

Operating Income

-$48M-199.2% margin

Net Income

-$59M-244.1% margin

EPS (Diluted)

$-0.63

Cash Flow

Operating Cash Flow

-$143M

Free Cash Flow

-$143M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$204M

Total Liabilities

$47M

Stockholders' Equity

$156M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$322M	-92.5%
Gross Profit	$22M	$319M	-93.1%
Operating Income	-$48M	$141M	-133.8%
Net Income	-$59M	$130M	-145.0%